Consumer Defensive -
Household & Personal Products - NYSE - US
$ 21.77
-2.51 %
$ 41.6 B
Market Cap
40.31
P/E
1. INTRINSIC VALUE
Balance Sheet
Kenvue Inc.
| Current Assets | 5.52 B |
| Cash & Short-Term Investments | 1.07 B |
| Receivables | 2.66 B |
| Other Current Assets | 1.8 B |
| Non-Current Assets | 20.1 B |
| Long-Term Investments | 0 |
| PP&E | 1.85 B |
| Other Non-Current Assets | 18.2 B |
| Current Liabilities | 5.74 B |
| Accounts Payable | 2.25 B |
| Short-Term Debt | 1.55 B |
| Other Current Liabilities | 1.93 B |
| Non-Current Liabilities | 10.2 B |
| Long-Term Debt | 7.06 B |
| Other Non-Current Liabilities | 3.14 B |
EFFICIENCY
Earnings Waterfall
Kenvue Inc.
| Revenue | 15.5 B |
| Cost Of Revenue | 6.5 B |
| Gross Profit | 8.96 B |
| Operating Expenses | 7.12 B |
| Operating Income | 1.84 B |
| Other Expenses | 811 M |
| Net Income | 1.03 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Kenvue Inc.
| Net Income | 1.03 B |
| Depreciation & Amortization | 622 M |
| Capital Expenditures | -434 M |
| Stock-Based Compensation | 254 M |
| Change in Working Capital | 0 |
| Others | 148 M |
| Free Cash Flow | 1.34 B |
Wall Street Analysts Price Targets
Kenvue Inc.
Wall Street analysts predict an average 1-year price target for KVUE of $24.6 , with forecasts ranging from
a
low of
$21 to a high of $29 .
KVUE Lowest Price Target
Wall Street Target
21 USD
-3.54%
KVUE Average Price Target
Wall Street Target
24.6 USD
12.87%
KVUE Highest Price Target
Wall Street Target
29 USD
33.21%
4. DIVIDEND
ANALYSIS
0.97%
DIVIDEND YIELD
0.205 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Kenvue Inc.
Sold
0-3 MONTHS
394 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
OGX® Haircare Introduces Shay Mitchell as First Global Brand Ambassador
New campaign introduces new Bond Protein Repair hair line designed to deliver effective bonding repair – at a fraction of the price of prestige brands SUMMIT, N.J. , April 7, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE ) announces actress and entrepreneur, Shay Mitchell, as the global brand ambassador for OGX®, stepping in as the face of the brand's Fixer character in their new campaign.
prnewswire.com
- 1 week ago
Wall Street Says 1970s Stagflation Possible: 4 Safe High-Yield Dividend Kings to Grab Now
If you were a big fan of “That '70s Show,” get ready because we may soon get a revival, and it will likely not be as entertaining.
247wallst.com
- 2 weeks ago
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
seekingalpha.com
- 2 weeks ago
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign
The Brand's Latest Mineral Sunscreen AddressesTop Consumer Barriers to Daily Sunscreen Use SUMMIT, N.J. , March 31, 2025 /PRNewswire/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid Mineral Sunscreen SPF 70.
prnewswire.com
- 2 weeks ago
Buy 3 'Safer' Dividend Kings Of 25 From March's 55
The article highlights 55 Dividend Kings, noting that five of the top ten by yield offer annual dividends from a $1K investment exceeding their single share prices. Analysts predict top-ten Kingly net gains ranging from 12.57% to 50.26% for March 2026, with six out of ten top-yield Kings expected to be top gainers. Sixteen out of fifty-five Kings show negative free cash flow margins, making them cash-poor and unsafe to buy; focus on safer Kings like Altria, United Bankshares, and Hormel.
seekingalpha.com
- 3 weeks ago
Tariffs Could Keep the Federal Reserve on Hold: 5 High-Yield Dividend Kings Are Our Top Calls
High-yield dividend stocks are a favorite among investors for good reason.
247wallst.com
- 3 weeks ago
2025 Dividend Kings: Strong Run Continues
The Dividend Kings are outperforming the S&P 500 in 2025 by 4.57%. Top performers include National Fuel & Gas (+30.21%), Consolidated Edison (+22.66%), and AbbVie (+20.40%). Promising Dividend Kings identified in February showed relative outperformance, averaging -0.38% vs. -1.58% for all Kings and -3.34% for SPY.
seekingalpha.com
- 4 weeks ago
Kenvue Ribbon-Cutting Marks Official Opening of New Global Headquarters in Summit, New Jersey
SUMMIT, N.J.--(BUSINESS WIRE)--Today, Kenvue Inc. (NYSE: KVUE) held a ribbon-cutting ceremony for its new 290,000 sq. ft. global headquarters in Summit, New Jersey.
businesswire.com
- 1 month ago
Kenvue + Johnson & Johnson: I Choose To Own The Whole 'Humpty Dumpty'
Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for accumulation during market volatility. Despite being off their highs, both JNJ and Kenvue present attractive buying opportunities due to their low betas and relatively high dividends. These are exactly the resilient defensive stocks in an un-loved healthcare sector that investors are now piling into as the VIX spikes.
seekingalpha.com
- 1 month ago
Buy 2 March S&P 500 Dividend Aristocrats Out Of 37 'Safer'
Four of the ten lowest-priced Dividend Aristocrats, including Franklin Resources and Realty Income, are ready to buy with annual dividends exceeding their single share prices. Analysts forecast 15.93% to 26.49% net gains for top-ten Aristocrat Dogs by March 2026, with Federal Realty and Stanley Black & Decker leading. A market correction of 65% could make all top-yield Aristocrats fair-priced, with dividends from $1K invested meeting or exceeding their single share prices.
seekingalpha.com
- 1 month ago
Recession Could Be Coming: 5 Strong Buy High-Yield Dividend Stocks That Will Still Outperform
The last time the economy experienced two negative quarters of gross domestic product was the first and second quarters of 2022, with a 1.6% pullback in the first quarter and a 0.6% decline in the second.
247wallst.com
- 1 month ago
Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set for March 7-11, 2025 at the Orlando Convention Center in Orlando, Florida. In findings from the 14 clinical studies detailing new Kenvue scientific research, the Company will present evidence alongside industry.
businesswire.com
- 1 month ago
8. Profile
Summary
Kenvue Inc. KVUE
COUNTRY
US
INDUSTRY
Household & Personal Products
MARKET CAP
$ 41.6 B
Dividend Yield
0.97%
Description
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Contact
199 Grandview Road, Skillman, NJ, 08558
https://www.kenvue.com
IPO
Date
May 4, 2023
Employees
22000
Officers
Ms. Meredith Stevens
Chief Operations Officer
Mr. Matthew Orlando
General Counsel
Mr. Thibaut Mongon
Chief Executive Officer & Director
Mr. Carlton Lawson
Group President of EMEA & Latin America
Ms. Sofya Tsinis
Head of Investor Relations
Ms. Ellie Bing Xie
Group President of Asia Pacific
Ms. Heather R. Howlett
Chief Accounting Officer
Mr. Paul Ruh
Chief Financial Officer
Mr. Bernardo Tavares
Chief Data & Technology Officer
Dr. Caroline Tillett Ph.D.
Chief Scientific Officer